Altered virulence of vaccine strains of measles virus after prolonged replication in human tissue

Journal of Virology

Volumn 73, Issue 10, 1999, Pages 8791-8797

  Valsamakis, Alexandra ^a,b   Auwaerter, Paul G ^a,b   Rima, Bert K ^c   Kaneshima, Hideto ^d   Griffin, Diane E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; MATRIX PROTEIN; MEASLES VACCINE; THREONINE; TRYPAN BLUE; VIRUS HEMAGGLUTININ;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MEASLES VIRUS; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCID MOUSE; SEQUENCE ANALYSIS; THYMOCYTE; THYMUS; VERO CELL; VIRUS GENE; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; XENOGRAFT;

EID: 0032824137     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.10.8791-8797.1999     Document Type: Article

References (31)

1. Angel, J. B., P. Walpita, R. A. Lerch, M. S. Sidhu, M. Masurekar, R. A. DeLellis, J. T. Noble, D. R. Snydman, aid S. A. Udem. 1998. Vaccine-associated measles pneumonitis in an adult with AIDS. Ann. Intern. Med. 129:104-106.
2. Auwaerter, P. G., H. Kaneshima, J. M. McCune, G. Wiegand, and D. E. Griffin. 1996. Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J. Virol. 70:3734-3740.
3. Auwaerter, P. G., P. A. Rota, W. R. Elkins, R. J. Adams, T. DeLozier, Y. Shi, W. J. Bellini, B. R. Murphy, and D. E. Griffin. Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis., in press.
4. Blixenkrone-Moller, M., A. Bernard, A. Bencsik, N. Sixt, L. E. Diamond, J. S. Logan, and T. F. Wild. 1998. Role of CD46 in measles virus infection in CD46 transgenic mice. Virology 249:238-248.
5. Centers for Disease Control and Prevention. 1998. Progress toward global measles control and regional elimination, 1990-1997. Morbid. Mortal. Weekly Rep. 47:1049-1054.
6. CLUSTALW software. 25 June 1999, revision date. [Online.] http://dot.imgen .bcm.tmc.edu:9331/multi-align/multi-align/html. Baylor College of Medicine, Houston, Tex. 29 July 1999, last date accessed.
7. Curran, M. D., and B. K. Rima. 1988. Nucleotide sequence of the gene encoding the matrix protein of a recent measles virus isolate. J. Gen. Virol. 69:2407-11.
8. Hilleman, M., E. Buynak, R. Weibel, J. Stokes, J. Whitman, and M. Leagus. 1968. Development and evaluation of the Moraten measles vaccine. JAMA 206:587-590.
9. Hofman, K., and M. Buron. 17 July 1999, revision date. BOXSHADE, version 3.21. [Online.] http://www.isrec.isb-sib.ch/software/BOX_form.html. 29 July 1999, last date accessed.
10. Hsu, E. C., F. Sarangi, C. Iorio, M. S. Sidhu, S. A. Udem, D. L. Dillehay, W. Xu, P. A. Rota, W. J. Bellini, and C. D. Richardson. 1998. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J. Virol. 72:2905-2916.
11. Langedijk, J. P. M., F. J. Daus, and J. T. van Oirschot. 1997. Sequence and structure alignment of paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J. Virol. 71:6155-6167.
12. Lecouturier, V., J. Fayolle, M. Caballero, J. Carabana, M. L. Celma, R. Fernandez-Munoz, T. F. Wild, and R. Buckland. 1996. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J. Virol. 70:4200-4204.
13. Lennette, E. H., and N. J. Schmidt. 1969. Diagnostic procedures for viral and rickettsial infections. American Public Health Association, New York, N.Y.
14. Mawhinney, H., I. V. Allen, J. M. Beare, J. M. Bridges, J. H. Connolly, M. Haire, N. C. Nevin, D. W. Neill, and J. R. Hobbs. 1971. Dysgammaglobulinemia complicated by disseminated measles. Br. Med. J. 2:380-381.
15. McChesney, M. B., C. J. Miller, P. A. Rota, Y. D. Zhu, L. Antipa, N. W. Lerche, R. Ahmed, and W. J. Bellini. 1997. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 233:74-84.
16. Mitus, A., A. Holloway, A. E. Evans, and J. F. Enders. 1962. Attenuated measles vaccine in children with acute leukemia. Am. J. Dis. Child. 103:413-418.
17. Monafo, W. J., D. B. Haslam, R. L. Roberts, S. R. Zaki, W. J. Bellini, and C. M. Coffin. 1994. Disseminated measles infection after vaccination in a child with a congenital immunodeficiency. J. Pediatr. 124:273-276.
18. Mrkic, B., J. Pavlovic, T. Rulicke, P. Volpe, C. J. Buchholz, D. Hourcade, J. P. Atkinson, A. Aguzzi, and R. Cattaneo. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:7420-7.
19. Namikawa, R., K. N. Weilbaecher, H. Kaneshima, E. J. Yee, and J. M. McCune. 1990. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172:1055-1063.
20. Rall, G. F., M. Manchester, L. R. Daniels, E. M. Callahan, A. R. Belman, and M. B. A. Oldstone. 1997. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. USA 94:4659-4663.
21. Rima, B. K., J. A. Earle, K. Baczko, V. ter Meulen, U. G. Liebert, C. Carstens, J. Carabana, M. Caballero, M. L. Celma, and R. Fernandez-Munoz. 1997. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 78:97-106.
22. Rota, J. S., Z. D. Wang, P. A. Rota, and W. J. Bellini. 1994. Comparison of sequences of the H, F, and N coding genes of measles virus vaccine strains. Virus Res. 31:317-330.
23. Schwarz, A., et al. 1967. Extensive clinical evaluations of highly attenuated live measles vaccine. JAMA 199:26-30.
24. Schwarz, A. 1964. Immunization against measles: development and evaluation of a highly attenuated live measles vaccine. Ann. Paediatr. 202:241-252.
25. Skiadopoulos, M. H., A. P. Durbin, J. M. Tatem, S. L. Wu, M. Paschalls, T. Tao, P. L. Collins, and B. R. Murphy. 1998. Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypes. J. Virol. 72:1762-1768.
26. Skiadopoulos, M. H., S. Surman, J. M. Tatem, M. Paschalis, S. L. Wu, S. A. Udem, A. P. Durbin, P. L. Collins, and B. R. Murphy. 1999. Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine. J. Virol. 73:1374-1381.
27. Takeda, M., A. Kato, F. Kobune, H. Sakata, Y. Li, T. Shioda, Y. Sakai, M. Asakawa, and Y. Nagai. 1998. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72:8690-8696.
28. Valsamakis, A., H. Schneider, P. G. Auwaerter, H. Kaneshima, M. A. Billeter, and D. E. Griffin. 1998. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72: 7754-61.
29. van Binnendijk, R. S., R. W. J. van der Heijden, and A. D. M. E. Osterhaus. 1995. Monkeys in measles research. Curr. Top. Microbiol. Immunol. 191: 135-148.
30. Whitehead, S. S., C. Y. Firestone, R. A. Karron, J. E. Crowe, Jr., W. R. Elkins, P. L. Collins, and B. R. Murphy. 1999. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/ 1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. J. Virol. 73:871-877.
31. Yanagi, Y., H. L. Hu, T. Seya, and H. Yoshikura. 1994. Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46. Arch. Virol. 138:39-53.